Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression

Bias in meta-analysis detected by a simple, graphical test

Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722

Meta-analysis in clinical trials

DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552

Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs

Concato, J., Shah, N., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422507 · Cited by 3,563

Publication and related bias in meta-analysis

Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282

A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality

Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M., Michaud, S., Bourgault, A., Nguyen, T., Frenette, C. H., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,962

Use of Gastric Acid–Suppressive Agents and the Risk of Community-Acquired Clostridium difficile –Associated Disease

Dial, S. (2005) · JAMA · doi:10.1001/jama.294.23.2989 · Cited by 954

Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs

Laheij, R. J. F. (2004) · JAMA · doi:10.1001/jama.292.16.1955 · Cited by 879

A Large Outbreak ofClostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use

Muto, C. A., Pokrywka, M., Shutt, K. A., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T. L., Croyle, K. S., Krystoflak, S., Patel-Brown, S., et al. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502539 · Cited by 619

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

Dial, S. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040876 · Cited by 577

Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding

Barkun, A. N., Bardou, M., Marshall, J. K., & for the Nonvariceal Upper GI Bleeding Consensus Conference Group* (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00012 · Cited by 540

Risk of fall in patients taking proton pump inhibitors: a meta-analysis

Lapumnuaypol, K., Thongprayoon, C., Wijarnpreecha, K., Tiu, A. C., & Cheungpasitporn, W. (2018) · QJM · doi:10.1093/qjmed/hcy245 · Cited by 16

Gastroesophageal Reflux

Sullivan, J. S., & Sundaram, S. S. (2012) · Pediatrics in Review · doi:10.1542/pir.33-6-243 · Cited by 16

Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: A randomized clinical trial

Compare, D., Rocco, A., Sgamato, C., Coccoli, P., Campo, S. M. A., Nazionale, I., Larussa, T., Luzza, F., Chiodini, P., & Nardone, G. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.01.004 · Cited by 15

Sociedade Portuguesa de Cuidados Intensivos guidelines for stress ulcer prophylaxis in the intensive care unit

Mendes, J. J., Silva, M. J., Miguel, L. S., Gonçalves, M. A., Oliveira, M. J., de Oliveira, C. C. A. L., & Gouveia, J. (2019) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20190002 · Cited by 26

Risk of peritonitis after gastroscopy in peritoneal dialysis patients

Chan, G. C., Wong, S. H., Ng, J. K., Li, P. K., Szeto, C., & Chow, K. M. (2021) · Peritoneal Dialysis International · doi:10.1177/08968608211018608 · Cited by 15

Probiotics Administration in Cystic Fibrosis: What Is the Evidence?

Esposito, S., Testa, I., Zani, E. M., Cunico, D., Torelli, L., Grandinetti, R., Fainardi, V., Pisi, G., & Principi, N. (2022) · Nutrients · doi:10.3390/nu14153160 · Cited by 15

Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients – focus on esomeprazole

Wu, J. C. Y., & Tang, R. S. Y. (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s41350 · Cited by 15

Balancing the Risks and Benefits of Proton Pump Inhibitors

Gill, J. M., Player, M. S., & Metz, D. C. (2011) · The Annals of Family Medicine · doi:10.1370/afm.1269 · Cited by 15

Síntomas intestinales en pacientes que reciben inhibidores de bomba de protones (IBP). Resultados de una encuesta multicéntrica en México

Schmulson, M. J., & Frati-Munari, A. C. (2019) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2018.02.008 · Cited by 14

La carrera de un mercader judeoconverso en el Nápoles español. Negocios y relaciones políticas de Miguel Vaaz (1590-1616)

Crivelli, B. M., & Sabatini, G. (2016) · Hispania-revista Espanola De Historia · doi:10.3989/hispania.2016.010 · Cited by 14

Proton pump inhibitor therapy usage and associated hospitalization rates and critical care outcomes of COVID-19 patients

Shupp, B., Mehta, S. V., Chirayath, S. G., Patel, N., Aiad, M., Sapin, J. E., Stoltzfus, J. C., & Schneider, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-11680-0 · Cited by 14

Prescribing errors in post - COVID-19 patients: prevalence, severity, and risk factors in patients visiting a post - COVID-19 outpatient clinic

Mahomedradja, R. F., van den Beukel, T. O., van den Bos, M., Wang, S., Kalverda, K. A., Lissenberg-Witte, B. I., Kuijvenhoven, M. A., Nossent, E. J., Muller, M., Sigaloff, K., et al. (2022) · BMC Emergency Medicine · doi:10.1186/s12873-022-00588-7 · Cited by 14

Proton Pump Inhibitor Use before Percutaneous Endoscopic Gastrostomy Is Associated with Adverse Outcomes

Im, J. P., Cha, J. M., Kim, J. W., Kim, S., Ryu, D. Y., Kim, E. Y., Kim, E. R., & Chang, D. K. (2014) · Gut and Liver · doi:10.5009/gnl.2014.8.3.248 · Cited by 14

Effets indésirables émergents des inhibiteurs de la pompe à protons

Bourne, C., Charpiat, B., Charhon, N., Bertin, C., Gouraud, A., Mouchoux, C., Skalli, S., & Janoly-Duménil, A. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.09.016 · Cited by 16

Maintenance of Efficacy and Safety of Rabeprazole in Children With Endoscopically Proven GERD

Haddad, I., Kierkuś, J., Tron, E., Ulmer, A., Hu, P., Silber, S. A., Sloan, S., & Leitz, G. J. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000229 · Cited by 14

A Meta-Analysis of Proton Pump Inhibitor Use and the Risk of Acute Kidney Injury: Geographical Differences and Associated Factors

Han, C.-T., Islam, M. M., Poly, T. N., Lu, Y.-C., & Lin, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072467 · Cited by 14

Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients

Huang, C.-H., Tseng, Y.-H., Tsai, W.-S., Su, C., Cheng, C.-L., Yang, Y. K., Chang, Y., & Liu, Y.-H. (2024) · Infectious Diseases and Therapy · doi:10.1007/s40121-024-00922-5 · Cited by 13

Proton pump inhibitor effect on macrophage and neutrophil function: a systematic review

Fowler, J. F., Eubank, T. A., & Garey, K. W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1477993 · Cited by 13

Barrett's esophagus: proton pump inhibitors and chemoprevention II

Richter, J. E., Penagini, R., Pohl, D., Dvorak, K., Goldman, A. J., Savarino, E. V., Zentilin, P., Savarino, V., Watson, J. T., Wong, R. K. H., et al. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06048.x · Cited by 13

Gesammelte Werke von Robert Koch

(1912) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0029-1189489 · Cited by 13

Factores de riesgo para la infección por Clostridium difficile

Becerra, M. G., Ospina, S., Atehortúa, S., & Fernández, D. Y. B. (2011) · Infectio · doi:10.1016/s0123-9392(11)70735-4 · Cited by 12

Malaria parasite infection compromises colonization resistance to an enteric pathogen by reducing gastric acidity

Walker, G. T., Yang, G., Tsai, J. Y., Rodriguez, J. L., English, B. C., Faber, F., Souvannaseng, L., Butler, B. P., & Tsolis, R. M. (2021) · Science Advances · doi:10.1126/sciadv.abd6232 · Cited by 12

Use of food and food-derived products in the treatment of gastritis: A systematic review

Duque-Buitrago, L. F., Tornero-Martínez, A., Loera‐Castañeda, V., & Mora‐Escobedo, R. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2024131 · Cited by 12

Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection

Feuerstadt, P., Allegretti, J. R., Dubberke, E. R., Guo, A. X., Harvey, A., Yang, M., García-Horton, V., Fillbrunn, M. K., Tillotson, G., Bancke, L. L., et al. (2024) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00907-w · Cited by 12

Proton pump Inhibitors and Risk of Enteric Infection in Inflammatory Bowel Disease: A Self-controlled Case Series

Varma, S., Trudeau, S. J., Li, J., & Freedberg, D. E. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad035 · Cited by 12

Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection

Marra, F., & Ng, K. (2015) · Drugs · doi:10.1007/s40265-015-0422-x · Cited by 12

Gastroenteritis in a Taipei emergency department: aetiology and risk factors

Lai, C.-C., Wu, F., Ji, D. D., Mu, J.-J., Yang, J., Chiu, K.-T., Lin, W.-Y., Li, C. Y., Fu, Y., Chen, W.-T., et al. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03377.x · Cited by 12

Proton Pump Inhibitors in Allergy: Benefits and Risks

Robinson, L. B., & Ruffner, M. A. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.09.022 · Cited by 12

Risks of proton‐pump inhibitors: what every doctor should know

Talley, N. J. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02305.x · Cited by 12

Proton pump inhibitors are not associated with an increased risk of Clostridioides difficile infection: a systematic review and meta-analysis of randomized controlled trials

Floria, D., Obeidat, M., Váncsa, S., Kávási, S. B., Földvári-Nagy, L., Hegyi, P. J., Veres, D. S., Drug, V. L., & Erőss, B. M. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2562341 · Cited by 11

Salmonella enteritidis causing myocarditis in a previously healthy 22-year-old male

Sundbom, P., Suutari, A., Abdulhadi, K., Broda, W., & Csegedi, M. (2018) · Oxford Medical Case Reports · doi:10.1093/omcr/omy106 · Cited by 11

Targeting the altered duodenal microenvironment in functional dyspepsia

Ceulemans, M., Wauters, L. I., & Vanuytsel, T. (2023) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2023.102363 · Cited by 12

Gastroesophageal Reflux Disease

Harnik, I. G. (2015) · Annals of Internal Medicine · doi:10.7326/aitc201507070 · Cited by 11

Association Between Use of Proton Pump Inhibitors and a Clostridium difficile– Associated Disease Outbreak: Case–Control Study

Linney, S., Fernandes, T., Einarson, T. R., Sengar, A., Walker, J. H., & Mills, A. (2010) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v63i1.866 · Cited by 11

Protonenpumpenhemmer – Nebenwirkungen und Komplikationen der langfristigen Protonenpumpenhemmereinnahme

Ueberschaer, H., & Allescher, H. (2017) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0042-121265 · Cited by 11

Long-term proton pump inhibitor therapy leads to small bowel bacterial overgrowth as determined by breath hydrogen and methane excretion

Sieczkowska, A., Landowski, P., Gibas, A., Kamińska, B., & Lifschitz, C. H. (2017) · Journal of Breath Research · doi:10.1088/1752-7163/aa9dcf · Cited by 11

Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury

Hatakeyama, Y., Horino, T., Matsumoto, T., Terada, Y., & Okuhara, Y. (2021) · Clinical and Experimental Nephrology · doi:10.1007/s10157-021-02066-z · Cited by 11

Clostridium difficile Infection in Lung Cancer Patients

Hwang, K., Hwang, Y., Seol, C., Park, C., Park, S., Yoon, K., Park, D., Lee, M., Jeong, E., & Kim, H.-R. (2013) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.66.379 · Cited by 11

Gastroenteritis in older people living in the community: results of two Australian surveys

Kirk, M., HALL, G., & Becker, N. G. (2012) · Epidemiology and Infection · doi:10.1017/s0950268811002834 · Cited by 12

Clostridium difficileInfection: What's New?

Seo, G. S. (2013) · Intestinal Research · doi:10.5217/ir.2013.11.1.1 · Cited by 10

Patient and physician predictors of inappropriate acid‐suppressive therapy (AST) use in hospitalized patients

Nachnani, J. S., Bulchandani, D. G., Moormeier, J. A., & Foxworth, J. W. (2009) · Journal of Hospital Medicine · doi:10.1002/jhm.492 · Cited by 10

Clinical and demographic profile and risk factors for Clostridium difficile infection

Carvajal, C., Pacheco, C., & Jaimes, F. A. (2017) · Biomédica · doi:10.7705/biomedica.v37i1.2915 · Cited by 10

Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study

Kuo, C., Lin, C.-Y., Chen, C.-W., Hsu, C.-Y., Hsieh, S., Chiu, C., & Lin, W. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111063 · Cited by 10

Consenso chileno de prevención, diagnóstico y tratamiento de la diarrea asociada a Clostridium difficile

Hernández-Rocha, C., Pidal, P. C., Ajenjo, M. C., Quera, R., Quintanilla, M., Lubascher, J., Jemenao, M. I., Patricio Ibáñez, L., Álvarez-Lobos, M., Alexis Diomedi, P., et al. (2016) · Revista chilena de infectología · doi:10.4067/s0716-10182016000100020 · Cited by 10

Bowel symptoms in patients that receive proton pump inhibitors. Results of a multicenter survey in Mexico

Schmulson, M. J., & Frati-Munari, A. C. (2018) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2018.05.011 · Cited by 10

Epidemiology and risk factors for carbapenemase-producing Enterobacteriaceae carriage in the hospital: A population-based nested case-control study

Fan, M., Wong, S., Yu, Q., Li, P. H., Wu, P., Chan, E. W., Wong, I. C. K., Tun, H. M., Cowling, B. J., Cheng, V. C., et al. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.03.013 · Cited by 9

Long-Term Acid Inhibition: Benefits and Harms

Tepeš, B. (2011) · Digestive Diseases · doi:10.1159/000331519 · Cited by 9

Gastrointestinal tuberculosis is not associated with proton pump inhibitors: A retrospective cohort study

Hong, K. S. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i2.258 · Cited by 9

The possible risks of proton pump inhibitors

Gracie, D. J., & Ford, A. C. (2016) · The Medical Journal of Australia · doi:10.5694/mja16.00750 · Cited by 9

Proton Pump Inhibitor Exposure and Acute Myocardial Infarction Risk: A Nested Cohort Study

Tseng, H.-J., Cheng, C., Tsai, S., Lin, W.-C., Bai, Y., Tsai, C.-F., Su, T., Li, C., Chen, T., & Chen, M. (2021) · Cardiovascular Toxicology · doi:10.1007/s12012-021-09637-2 · Cited by 11

Severe symptomatic hypomagnesaemia induced by the chronic use of proton pump inhibitors: A case report of a patient with Zollinger–Ellison syndrome

Ströker, E., Leone, L., Vandeput, Y., Borbath, I., & Lefebvre, C. (2014) · Acta Clinica Belgica · doi:10.1179/0001551213z.0000000008 · Cited by 9

Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy

Zhou, S., Wang, S., Ma, Y., Tang, L., Shi, Y., Liang, B., Chen, Y., & Yu, K. (2016) · Hematology · doi:10.1080/10245332.2016.1142711 · Cited by 9

Reliable Implementation of Clinical Pathways: What Will It Take—That Is the Question

Simmons, J. M., & Kotagal, U. R. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.12.017 · Cited by 9

Widening spectrum of adverse effects caused by long-term use of proton pump inhibitors: A comprehensive review of literature

Mir, A., Wani, Z. A., Bhat, A. R., Fahelelbom, K. M., Kumar, A., & Ahmed, S. (2024) · LabMed discovery. · doi:10.1016/j.lmd.2024.100027 · Cited by 12

Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma

Iida, K., Naiki, T., Etani, T., Nagai, T., Sugiyama, Y., Isobe, T., Aoki, M., Nozaki, S., Noda, Y., Shimizu, N., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-53158-1 · Cited by 8

A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data

Litton, E., Eastwood, G. M., Bellomo, R., Beasley, R. W., Bailey, M., Forbes, A. B., Gattas, D. J., Pilcher, D. V., Webb, S. A. R., McGuinness, S., et al. (2014) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01466-7 · Cited by 8

Aspirin and Proton Pump Inhibitor Combination Therapy for Prevention of Cardiovascular Disease and Barrett's Esophagus

Peura, D. A., & Wilcox, C. M. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.01.2728 · Cited by 8

Clinical characterization and risk factors of Clostridium difficile infection in elderly patients in a Chinese hospital

Zhang, L., Dong, D., Jiang, C., Xuefeng, W., & Yibing, P. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.4816 · Cited by 8

The Effects of Food Composition on Foodborne Illness Infectious Dose and Host Susceptibility

Ponder, M. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-56836-2_17 · Cited by 8

Regulation of Gastric Acid Secretion

Schubert, M. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00047-6 · Cited by 9

Follow the Metaplasia: Characteristics and Oncogenic Implications of Metaplasia’s Pattern of Spread Throughout the Stomach

Sáenz, J. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.741574 · Cited by 8

Patients with Clostridium difficile infection and prior appendectomy may be prone to worse outcomes

Shaikh, D. H., Patel, H. K., Munshi, R., Sun, H., Mehershahi, S., Baiomi, A., Alemam, A., Pirzada, U. A., Nawaz, I., Naher, K., et al. (2021) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v13.i11.1436 · Cited by 8

Proton pump inhibitors: concerns over prolonged use.

Mouli, V. P., & Ahuja, V. (2011) · PubMed · Cited by 8

Factors Affecting Treatment and Recurrence of Clostridium difficile Infections

Matsumoto, K., Kanazawa, N., Shigemi, A., Ikawa, K., Morikawa, N., Koriyama, T., Orita, M., Kawamura, H., Tokuda, K., Nishi, J., et al. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00492 · Cited by 8

The Microbiota and infectious diarrhea

Surawicz, C. M. (2010) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(10)70018-x · Cited by 8

Gastroprotection in NSAID and low-dose aspirin users: A cross-sectional study in primary care

Lanas, Á., Plazas, M. J., Gimeno, E., & Muñoz‐Tudurí, M. (2011) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2011.10.004 · Cited by 8

NHG Standaard Maagklachten (tweede herziening)

Numans, M. E., de Wit, N. J., Dirven, J. A. M., Heemstra-Borst, C. G., Hurenkamp, G. B., Scheele, M., Burgers, J. S., Geijer, R. M. M., & de Jongh, E. (2013) · Pure Amsterdam UMC · Cited by 8

Controversial link between proton pump inhibitors and anticancer agents: review of the literature

Meriggi, F. A. (2021) · Tumori Journal · doi:10.1177/03008916211025091 · Cited by 8

Gastroesophageal Reflux Disease

Richter, J. E., & Friedenberg, F. K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00043-3 · Cited by 8

Seguridad de los Inhibidores de la bomba de protones

Oscanoa, T. J. (2011) · Americanae (AECID Library) · doi:10.47892/rgp.2011.311.322 · Cited by 8

Prospective Randomized Controlled Clinical Trial of the Long-Term Effects of Omeprazole on Healthy Dogs

Gil, L., Martín, G., Soler, C., Vila, A., Saiz, M. R., & Navarro, P. F. (2024) · Animals · doi:10.3390/ani14081168 · Cited by 7

Bowel preparation before colonoscopy: Consequences, mechanisms, and treatment of intestinal dysbiosis

Zheng, Z.-L., Zheng, Q.-F., Wang, L., & Liu, Y. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i2.100589 · Cited by 9

Does this patient have Clostridioides difficile infection? A systematic review and meta-analysis

Manzoor, F., Manzoor, S., Pinto, R. L., Brown, K. A., Langford, B. J., & Daneman, N. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.06.010 · Cited by 7

Streptococcus agalactiae meningoencephalitis associated with gastroesophageal reflux disease and chronic proton pump inhibitors use, in a 9 month-old infant: a case report

Bîrluțiu, V., Luca, C. M., & Bîrluţiu, R. M. (2018) · BMC Pediatrics · doi:10.1186/s12887-018-0995-0 · Cited by 7

Current Status of Chemoprevention in Barrett’s Esophagus

Moayyedi, P., & El‐Serag, H. B. (2020) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2020.08.008 · Cited by 7

Characteristics, Risk Factors, and Prevalence of Clostridioides difficile Among Hospitalized Patients in a Tertiary Care Hospital in Palestine

Abukhalil, A. D., AbuKhdeir, L., Hamed, M., Al-Shami, N. A., Naseef, H., Aiesh, B. M., & Sabateen, A. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s333985 · Cited by 7

Characteristics of patients withClostridium difficileinfection in Taiwan

LIN, Y.-C., Huang, Y., LEE, T.-F., Lee, N.-Y., Liao, C., Lin, S.-Y., Ko, W., & Hsueh, P. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812002749 · Cited by 7

Gastrointestinal Complications of Antirheumatic Drugs

Rainsford, K. D., Kean, I. R. L., & Kean, W. F. (2017) · Technical report · doi:10.1016/b978-0-444-63707-9.00023-4 · Cited by 7

Need for a Randomized Controlled Trial of Stress Ulcer Prophylaxis in Critically Ill Children: A Canadian Survey

Duffett, M., Choong, K. L. M., Foster, J. R., Gilfoyle, E., Lacroix, J., & Cook, D. J. (2017) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v70i4.1679 · Cited by 7

Proton Pump Inhibitors: Are They a Real Threat to the Patient?

Xavier, S. A., Magalhães, J. T., & Cotter, J. B. (2018) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000487154 · Cited by 7

Clinical Update on Nursing Home Medicine: 2011

Messinger‐Rapport, B. J., Morley, J. E., Thomas, D. R., & Gammack, J. K. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.08.007 · Cited by 7

Safety and Efficacy of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer: Focus on Challenging Populations

Zullo, L., Rossi, G., Dellepiane, C., Tagliamento, M., Alama, A., Coco, S., Longo, L., Pronzato, P., Maria, A. D., & Genova, C. (2021) · Immunotherapy · doi:10.2217/imt-2020-0226 · Cited by 7

Review of pharmacokinetic and pharmacodynamic modeling and safety of proton pump inhibitors and aspirin

Gesheff, M. G., Franzese, C. J., Bliden, K. P., Contino, C., Rafeedheen, R., Tantry, U. S., & Gurbel, P. A. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.945428 · Cited by 7

Risk of Clostridium diffcile Infection With Acid-Suppressive Therapy; Pitfalls in Accurate Estimation

Chandra, S., Agarwal, D., & Surana, A. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.394 · Cited by 7

Gastric acid suppressants--too much of a good thing?

Logan, I., Sumukadas, D., & Witham, M. D. (2010) · Age and Ageing · doi:10.1093/ageing/afq057 · Cited by 7

Kidney Toxicity of Drugs for the Heart: An Updated Perspective

Caiati, C., Arrigoni, R., Stanca, A., & Lepera, M. E. (2025) · Metabolites · doi:10.3390/metabo15030191 · Cited by 6

Physicians’ perceptions and awareness of adverse effects of proton pump inhibitors and impact on prescribing patterns

Awad, A. I., Al-Tunaib, A., & Al-Saraf, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1383698 · Cited by 6

Enfermedad asociada a Clostridium difficile: nuevas amenazas de un viejo enemigo

Sánchez, A. L., Otero, W. A., & Caminos, J. E. (2008) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 6

Seguridad e interacciones de los inhibidores de la bomba de protones: lecciones aprendidas en millones de pacientes

Esplugues, J. V., & Martí‐Cabrera, M. (2010) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(10)70004-2 · Cited by 6

History of antimicrobial use and the risk of Dientamoeba fragilis infection

Röser, D., Simonsen, J., Nielsen, H. V., Stensvold, C. R., & Mølbak, K. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2334-9 · Cited by 6

Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid

Yeomans, N. D. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.42 · Cited by 6

Preoperative Gastroesophageal Reflux Disorder Is Associated With Increased Morbidity in Patients Undergoing Abdominal Surgery

Tilak, A. M., Ramirez, A. G., Turrentine, F. E., Sohn, M., & Jones, R. S. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.07.051 · Cited by 6

Proton Pump Inhibitor-Induced Galactorrhea in a Kidney Transplant Recipient: A Friend or Foe?

Prikis, M., MacDougall, J., & Narasimhadevara, N. (2020) · Case Reports in Transplantation · doi:10.1155/2020/8108730 · Cited by 6

Pharmacologic Options in the Management of Upper Gastrointestinal Bleeding: Focus on the Elderly

Kyaw, M. H., & Chan, F. K. L. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0173-5 · Cited by 6

Management of reflux after peroral endoscopic myotomy

Callahan, Z. M., Su, B., & Ujiki, M. B. (2019) · Journal of Xiangya Medicine · doi:10.21037/jxym.2019.01.02 · Cited by 6

A Health Insurance Company–Initiated Multifaceted Intervention for Optimizing Acid-Suppressing Drug Prescriptions in Primary Care

Smeets, H. M., de Wit, N. J., Zuithoff, N. P. A., van Dijk, P. C. M., van der Lee, A. P. M., & Hoes, A. W. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.224 · Cited by 6

Advances in the Surgical Management of Gastroesophageal Reflux

Sandoval, J. A., & Partrick, D. A. (2010) · Advances in Pediatrics · doi:10.1016/j.yapd.2010.09.004 · Cited by 6

Gene expression profiles induced by Salmonella infection in resistant and susceptible mice

Cawthraw, S. A., Pennings, J. L. A., Hodemaekers, H. M., de Jonge, R., Havelaar, A. H., Hoebee, B., Johnson, L. K., Best, A., Kennedy, E., Ragione, R. M. L., et al. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.01.001 · Cited by 6

Hospitalized patients on proton pump inhibitors for stress ulcer prophylaxis have a higher risk of Clostridioides difficile infection compared with those on histamine-2 receptor antagonists

Wu, L.-H., Wang, J., Liu, Y.-H., Su, C.-C., Yang, Y.-H. K., Lin, S.-J., & Cheng, C. (2024) · Journal of Hospital Infection · doi:10.1016/j.jhin.2024.09.016 · Cited by 5

Efficacy of Rebamipide in the Prevention of Nonsteroidal Anti-Inflammatory Drug-Induced Gastrointestinal Mucosal Breaks: A Systematic Review and Meta-Analysis

Cion, R. I. A., Juyad, I. G. A., & Yasay, E. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003535 · Cited by 5

Published by Blackwell Publishing Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression

(2015)

Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control Study

Kuo, C., Lin, C.-Y., Chen, C.-W., Hsu, C.-Y., Hsieh, S., Chiu, C., & Lin, W. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111063 · Cited by 10

Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

Bavishi, C., & DuPont, H. L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04874.x · Cited by 480

Acid suppression and enteric infection—a potentially explosive combination

Jones, K. (2013) · Evidence-Based Practice · doi:10.1097/01.ebp.0000540392.70736.d6

Acid-Suppressive Therapy and Risk for C. difficile Infection: A Systematic Review and Meta-Analysis

Oh, D., Kim, K.-R., Cheon, S., & Chung, J. E. (2024) · Journal of Pharmacoepidemiology and Risk Management · doi:10.56142/perm.24.0018